Skip to content

Analyses of Anemia in Very Low Birth Weight (VLBW) Infants.

Analyses of Anemia Risk Factors and Prognosis in VLBW Infants.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05949788
Enrollment
146
Registered
2023-07-18
Start date
2023-03-01
Completion date
2024-03-24
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The Risk Factors for Improving the Prognosis of VLBW Infants, Very Preterm Maturity of Infant

Keywords

VLBW, anemia, risk factors, prognosis

Brief summary

To study and analyze the association of the severity of anemia with neonatal morbidity and the risk factors of anemia in ealry life (less than 3 days of life) among the very low birth weight (VLBW) infants.

Detailed description

The rescue treatment of very low birth weight (VLBW) infants is the main task of our neonatal intensive care unit (NICU) is this era. Anemia of prematurity (AOP) is one of the most common complication of these infants, which can affect their growth, intelligence, behavior, immunity and hemodynamics, and even endanger their lives in severe situation. It is of great significance to investigate the association of the severity of anemia with neonatal morbidity and the risk factors of anemia in ealry life for improving the prognosis of these infants. Patient Registry procedures: First, the list of VLBW infants was obtained through medical record search, and sent to the principal investigator (PI) at each center when an infant was eligible for enrollment. Second, patients are included in this study according to the exclusion criteria by PI. Finally, the PI at each center will be responsible for the accuracy,completeness or representativeness of medical records, registry forms,data collection. Statistical analysis:The two groups were compared by a Χ2-test for categorical variables, Mann-Whitney U Test were used when reporting medians.A P value of \<0.05 was considered statistically significant.

Interventions

OTHERNo intervention

Retrospect study, no direct intervention

Sponsors

Longhua Hospital Of Baoan District, Shenzhen
CollaboratorOTHER
Shenzhen Bao'an Maternal and Child Health Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 4 Months
Healthy volunteers
No

Inclusion criteria

* Preterm infants less than 32 weeks of gestational age and birth weight below 1500 g and who survive to NICU are eligible for the trial. * Anemia was defined as a central venous hemoglobin harvested in the first 3 days of life less than two standard deviations below the mean for postnatal age.

Exclusion criteria

* Asphyxia (arterial pH \<7.0, fifth minute Apgar score \<3), * Twin-to twin-transfusion syndrome, * Discordant twins (difference in birth weight \>20%), * Major congenital anomalies or chromosomal anomalies, * Disagree of parents.

Design outcomes

Primary

MeasureTime frameDescription
The Incidence of Early Onset Sepsis in VLBW Infants With AOP.through study completion, an average of 6 monthsThe incidence of early onset sepsis in very low birth weigh (VLBW) infants with anemia of prematurity (AOP)

Secondary

MeasureTime frameDescription
The Maternal Hb Levels Before Birth Among VLBW Infants With AOP.Through study completion, an average of 6 monthsThe maternal hemoglobin (Hb) levels in very low birth weight (VLBW) infants with anemia of prematurity (AOP)
Mortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)Through study completion, an average of 6 monthsThe incidence of death and morbidity among extremely preterm infants with AOP and without.

Countries

China

Participant flow

Recruitment details

This was a retrospective study on the maternal and infant clinical and electronic records.146 extremely preterm infants with a gestational age of less than 28 weeks were admitted to Bao'an Women's and Children's Hospital affiliated with Jinan University and Longhua District Women's and Children's Hospital from January 1, 2020 to December 31, 2022.

Pre-assignment details

45 extremely preterm infants were excluded due to severe birth deformity, twin-twin transfusion syndrome, neonatal hemolytic disease, death within 14 days after birth or transfer to another hospital.

Participants by arm

ArmCount
Anemia Group
The very low birth weight (VLBW) infants meet the diagnostic criteria of neonatal anemia during hospitalization between January 2020 and January 2023. No intervention: Retrospect study, no direct intervention
25
Control Group
The very low birth weight (VLBW) infants are included without anemia during hospitalization between January 2020 and January 2023. No intervention: Retrospect study, no direct intervention
76
Total101

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall Studydeath within 14 days after birth26
Overall Studyneonatal hemolytic disease38
Overall Studysevere birth deformity27
Overall Studytransfer to another hospital26
Overall Studytwin-twin transfusion syndrome27

Baseline characteristics

CharacteristicControl GroupTotalAnemia Group
Age, Continuous
Gestational age
26.79 weeks (gestational age)26.43 weeks (gestational age)26 weeks (gestational age)
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
China
76 participants101 participants25 participants
Sex: Female, Male
Female
28 Participants39 Participants11 Participants
Sex: Female, Male
Male
48 Participants62 Participants14 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
5 / 3610 / 110
other
Total, other adverse events
20 / 3645 / 110
serious
Total, serious adverse events
5 / 3610 / 110

Outcome results

Primary

The Incidence of Early Onset Sepsis in VLBW Infants With AOP.

The incidence of early onset sepsis in very low birth weigh (VLBW) infants with anemia of prematurity (AOP)

Time frame: through study completion, an average of 6 months

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Anemia GroupThe Incidence of Early Onset Sepsis in VLBW Infants With AOP.Early onset sepsis18 Participants
Anemia GroupThe Incidence of Early Onset Sepsis in VLBW Infants With AOP.Non-early onset sepsis7 Participants
Control GroupThe Incidence of Early Onset Sepsis in VLBW Infants With AOP.Early onset sepsis34 Participants
Control GroupThe Incidence of Early Onset Sepsis in VLBW Infants With AOP.Non-early onset sepsis42 Participants
Secondary

Mortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)

The incidence of death and morbidity among extremely preterm infants with AOP and without.

Time frame: Through study completion, an average of 6 months

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Anemia GroupMortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)NEC3 Participants
Anemia GroupMortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)IVH7 Participants
Anemia GroupMortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)ROP (greater than II)12 Participants
Anemia GroupMortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)EUGR3 Participants
Anemia GroupMortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)neonatal sepsis17 Participants
Anemia GroupMortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)Death3 Participants
Anemia GroupMortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)moderate or severe BPD7 Participants
Control GroupMortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)Death4 Participants
Control GroupMortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)moderate or severe BPD20 Participants
Control GroupMortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)ROP (greater than II)39 Participants
Control GroupMortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)NEC6 Participants
Control GroupMortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)neonatal sepsis39 Participants
Control GroupMortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)IVH16 Participants
Control GroupMortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)EUGR14 Participants
Secondary

The Maternal Hb Levels Before Birth Among VLBW Infants With AOP.

The maternal hemoglobin (Hb) levels in very low birth weight (VLBW) infants with anemia of prematurity (AOP)

Time frame: Through study completion, an average of 6 months

ArmMeasureValue (MEDIAN)
Anemia GroupThe Maternal Hb Levels Before Birth Among VLBW Infants With AOP.111 g/L
Control GroupThe Maternal Hb Levels Before Birth Among VLBW Infants With AOP.107 g/L

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026